Clinical Trial Update: A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed the safety, tolerability, and pharmacokinetics (blood levels) of UCB0022 in healthy participants and in people with Parkinson's dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• UCB0022

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Healthy Study Participants, Parkinson's Disease | Phase 1 | Status: COMPLETED